Patient Portal

Foluso Olabisi Ademuyiwa, MD, MPH, MSCI

Associate Professor, Medicine
Division of Medical Oncology

Specialty Areas

Medical Oncology
Breast Oncology

Board Certifications

Medical Oncology
Internal Medicine
Pediatrics

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Medical Oncology, breast cancer, breast oncology

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129
Phone: 314-747-7222

Center for Advanced Medicine

4921 Parkview Place
St. Louis, MO 63110

Suite: A
Floor: 7

Education

Education

Master of Science in Clinical Investigation: Washington University School of Medicine, St. Louis, MO 2016
Fellowship, Hematology & Oncology: Indiana University School of Medicine, Indianapolis, IN 2009
Medical Degree: University of Ibadan College of Medicine, Ibadan, Nigeria 1999
Masters in Public Health: Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 2001
Chief Resident, Internal Medicine: Chief Resident, Bridgeport Hospital-Yale Combined Med-Peds Program 2006
Residency, Internal Medicine: Bridgeport Hospital-Yale Combined Med-Peds Program, CT 2006

Publication & Research

Publication & Research

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
Pernas S, Martin M, Kaufman PA, Gil-Martin M, Gomez Pardo P, Lopez-Tarruella S, Manso L, Ciruelos E, Perez-Fidalgo JA, Hernando C, Ademuyiwa FO, Weilbaecher K, Mayer I, Pluard TJ, Martinez Garcia M, Vahdat L, Perez-Garcia J, Wach A, Barker D, Fung S, Romagnoli B, Cortes J
Lancet Oncol. 2018 Jun; 19(6)812-824. doi: 10.1016/S1470-2045(18)30147-5.

PMID:
    29706375
    [PubMed - in process]
Related citations


Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO, Tao Y, Luo J, Weilbaecher K, Ma CX
Breast Cancer Res Treat. 2017 Feb; 161(3)491-499. doi: 10.1007/s10549-016-4062-y.

PMID:
    27915434
    [PubMed - indexed for MEDLINE]
Related citations


Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.
Tucker NS, Cyr AE, Ademuyiwa FO, Tabchy A, George K, Sharma PK, Jin LX, Sanati S, Aft R, Gao F, Margenthaler JA, Gillanders WE
Ann Surg. 2016 Dec; 264(6)1098-1102.

PMID:
    26779976
    [PubMed - indexed for MEDLINE]
Related citations


Managing breast cancer in younger women: challenges and solutions.
Ademuyiwa FO, Cyr A, Ivanovich J, Thomas MA
Breast Cancer (Dove Med Press). 2016; 81-12. doi: 10.2147/BCTT.S68848.

PMID:
    26730210
    [PubMed]
Related citations


Comparative Effectiveness of Biomarkers to Target Cancer Treatment: Modeling Implications for Survival and Costs.
Birnbaum JK, Ademuyiwa FO, Carlson JJ, Mallinger L, Mason MW, Etzioni R
Med Decis Making. 2016 Jul; 36(5)594-603. doi: 10.1177/0272989X15601998.

PMID:
    26304062
    [PubMed - indexed for MEDLINE]
Related citations


CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer.
Xiang J, Hurchla MA, Fontana F, Su X, Amend SR, Esser AK, Douglas GJ, Mudalagiriyappa C, Luker KE, Pluard T, Ademuyiwa FO, Romagnoli B, Tuffin G, Chevalier E, Luker GD, Bauer M, Zimmermann J, Aft RL, Dembowsky K, Weilbaecher KN
Mol Cancer Ther. 2015 Nov; 14(11)2473-85. doi: 10.1158/1535-7163.MCT-15-0252.

PMID:
    26269605
    [PubMed - indexed for MEDLINE]
Related citations


Reply to Differences in 25-hydroxyvitamin D concentrations may explain most of the black-white breast cancer disparities noted in young women.
Ademuyiwa FO
Cancer. 2015 Jun 15; 121(12)2098. doi: 10.1002/cncr.29280.

PMID:
    25678364
    [PubMed - indexed for MEDLINE]
Related citations


US breast cancer mortality trends in young women according to race.
Ademuyiwa FO, Gao F, Hao L, Morgensztern D, Aft RL, Ma CX, Ellis MJ
Cancer. 2015 May 1; 121(9)1469-76. doi: 10.1002/cncr.29178.

PMID:
    25483625
    [PubMed - indexed for MEDLINE]
Related citations


Neoadjuvant therapy in operable breast cancer: application to triple negative breast cancer.
Ademuyiwa FO, Ellis MJ, Ma CX
J Oncol. 2013; 2013219869. doi: 10.1155/2013/219869.

PMID:
    23983689
    [PubMed]
Related citations


Time-trends in survival in young women with breast cancer in a SEER population-based study.
Ademuyiwa FO, Groman A, Hong CC, Miller A, Kumar S, Levine E, Erwin D, Ambrosone C
Breast Cancer Res Treat. 2013 Feb; 138(1)241-8. doi: 10.1007/s10549-013-2425-1.

PMID:
    23371505
    [PubMed - indexed for MEDLINE]
Related citations


NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.
Ademuyiwa FO, Bshara W, Attwood K, Morrison C, Edge SB, Karpf AR, James SA, Ambrosone CB, O'Connor TL, Levine EG, Miliotto A, Ritter E, Ritter G, Gnjatic S, Odunsi K
PLoS One. 2012; 7(6)e38783. doi: 10.1371/journal.pone.0038783.

PMID:
    22761704
    [PubMed - indexed for MEDLINE]
Related citations


An 81-year-old patient with distant metastasis of invasive lobular carcinoma occurring 41 years after mastectomy.
Ademuyiwa FO, Khoury T, Warner J, Gannon J, Hwang H
Clin Breast Cancer. 2012 Aug; 12(4)293-5. doi: 10.1016/j.clbc.2012.03.012.

PMID:
    22595199
    [PubMed - indexed for MEDLINE]
Related citations


Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type.
Monhollen L, Morrison C, Ademuyiwa FO, Chandrasekhar R, Khoury T
Histopathology. 2012 Sep; 61(3)365-77. doi: 10.1111/j.1365-2559.2012.04230.x.

PMID:
    22486370
    [PubMed - indexed for MEDLINE]
Related citations


Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.
Khoury T, Ademuyiwa FO, Chandrasekhar R, Jabbour M, Deleo A, Ferrone S, Wang Y, Wang X
Mod Pathol. 2012 Mar; 25(3)388-97. doi: 10.1038/modpathol.2011.172.

PMID:
    22080062
    [PubMed - indexed for MEDLINE]
Related citations


Impact of body mass index on clinical outcomes in triple-negative breast cancer.
Ademuyiwa FO, Groman A, O'Connor T, Ambrosone C, Watroba N, Edge SB
Cancer. 2011 Sep 15; 117(18)4132-40. doi: 10.1002/cncr.26019.

PMID:
    21387276
    [PubMed - indexed for MEDLINE]
Related citations


The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort.
Ademuyiwa FO, Miller A, O'Connor T, Edge SB, Thorat MA, Sledge GW, Levine E, Badve S
Breast Cancer Res Treat. 2011 Apr; 126(3)797-802. doi: 10.1007/s10549-010-1329-6.

PMID:
    21197567
    [PubMed - indexed for MEDLINE]
Related citations


Breast cancer racial disparities: unanswered questions.
Ademuyiwa FO, Edge SB, Erwin DO, Orom H, Ambrosone CB, Underwood W 3rd
Cancer Res. 2011 Feb 1; 71(3)640-4. doi: 10.1158/0008-5472.CAN-10-3021.

PMID:
    21135114
    [PubMed - indexed for MEDLINE]
Related citations


Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores.
Ademuyiwa FO, Thorat MA, Jain RK, Nakshatri H, Badve S
Mod Pathol. 2010 Feb; 23(2)270-5. doi: 10.1038/modpathol.2009.172.

PMID:
    19946260
    [PubMed - indexed for MEDLINE]
Related citations


A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67.
Hahn NM, Zon RT, Yu M, Ademuyiwa FO, Jones T, Dugan W, Whalen C, Shanmugam R, Skaar T, Sweeney CJ
Ann Oncol. 2009 Dec; 20(12)1971-6. doi: 10.1093/annonc/mdp244.

PMID:
    19605506
    [PubMed - indexed for MEDLINE]
Related citations


The role of maintenance chemotherapy in advanced nonsmall cell lung cancer.
Jalal SI, Ademuyiwa FO, Hanna NH
Curr Opin Oncol. 2009 Mar; 21(2)110-5. doi: 10.1097/CCO.0b013e328322cf49.

PMID:
    19532011
    [PubMed - indexed for MEDLINE]
Related citations

Areas of Research Interest

Clinical trials in breast cancer especially in patients with triple negative disease, early-onset breast cancer, racial disparities.